Piramal Pharma Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 543635 |
NSE Symbol : PPLPHARMA |
P/E(TTM) : 57.82 |
ISIN Demat : INE0DK501011 |
Div & Yield% : 0.05 |
EPS(TTM) : 3.85 |
Book Value(₹) : 50.65 |
Market Cap(₹Cr) : 29,511.15 |
Face Value(₹) : 10.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 1,063.20 | 1,525.30 | 1,024.14 | 994.24 | 846.43 | 1,054.58 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 1,063.20 | 1,525.30 | 1,024.14 | 994.24 | 846.43 | 1,054.58 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 36.76 | 53.19 | 33.11 | 89.08 | 26.68 | 62.88 |
Total Income | 1,099.96 | 1,578.49 | 1,057.25 | 1,083.32 | 873.11 | 1,117.46 |
Total Expenditure | 911.57 | 1,135.66 | 898.61 | 908.08 | 829.84 | 965.03 |
PBIDT | 188.39 | 442.83 | 158.64 | 175.24 | 43.27 | 152.43 |
Interest | 24.88 | 27.66 | 17.42 | 28.22 | 33.80 | 33.78 |
PBDT | 163.51 | 415.17 | 141.22 | 147.02 | 9.47 | 118.65 |
Depreciation | 51.85 | 52.50 | 51.56 | 50.83 | 50.37 | 53.01 |
Tax | 27.43 | 87.24 | 17.50 | 7.74 | 0.00 | 23.66 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -1.04 | 2.35 | -2.18 | 11.29 | -7.54 | 0.28 |
Reported Profit After Tax | 85.27 | 273.08 | 74.34 | 77.16 | -33.36 | 41.70 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 85.27 | 273.08 | 74.34 | 77.16 | -33.36 | 41.70 |
EPS (Unit Curr.) | 0.64 | 2.06 | 0.56 | 0.61 | -0.28 | 0.35 |
EPS (Adj) (Unit Curr.) | 0.64 | 2.06 | 0.56 | 0.61 | -0.27 | 0.34 |
Calculated EPS (Unit Curr.) | 0.64 | 2.06 | 0.56 | 0.58 | -0.28 | 0.35 |
Calculated EPS (Adj) (Unit Curr.) | 0.64 | 2.06 | 0.56 | 0.58 | -0.27 | 0.34 |
Calculated EPS (Ann.) (Unit Curr.) | 2.58 | 8.26 | 2.25 | 2.33 | -1.12 | 1.40 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.58 | 8.26 | 2.25 | 2.33 | -1.09 | 1.37 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 1,322.95 | 1,322.95 | 1,322.95 | 1,322.95 | 1,193.32 | 1,193.32 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 17.72 | 29.03 | 15.49 | 17.63 | 5.11 | 14.45 |
PBDTM(%) | 15.38 | 27.22 | 13.79 | 14.79 | 1.12 | 11.25 |
PATM(%) | 8.02 | 17.90 | 7.26 | 7.76 | -3.94 | 3.95 |